

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation by symbiont of host defense response (GO:0052509) | 6.68564962 |
| 2 | modulation by symbiont of host defense response (GO:0052031) | 6.68564962 |
| 3 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 6.68564962 |
| 4 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 6.68564962 |
| 5 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 6.68564962 |
| 6 | modulation by symbiont of host immune response (GO:0052553) | 6.68564962 |
| 7 | regulation of interferon-beta biosynthetic process (GO:0045357) | 6.20664424 |
| 8 | mannose metabolic process (GO:0006013) | 5.91134241 |
| 9 | macrophage activation involved in immune response (GO:0002281) | 5.63169640 |
| 10 | microglial cell activation (GO:0001774) | 5.41567418 |
| 11 | negative regulation of granulocyte differentiation (GO:0030853) | 4.75102637 |
| 12 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 4.72037236 |
| 13 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 4.28564589 |
| 14 | keratan sulfate catabolic process (GO:0042340) | 4.22061525 |
| 15 | apoptotic cell clearance (GO:0043277) | 4.20496378 |
| 16 | barbed-end actin filament capping (GO:0051016) | 4.16050642 |
| 17 | virion attachment to host cell (GO:0019062) | 4.12875688 |
| 18 | adhesion of symbiont to host cell (GO:0044650) | 4.12875688 |
| 19 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.12858559 |
| 20 | positive regulation of interferon-alpha production (GO:0032727) | 4.06905426 |
| 21 | immunoglobulin mediated immune response (GO:0016064) | 4.00432043 |
| 22 | positive regulation of chemokine secretion (GO:0090197) | 3.98144246 |
| 23 | response to host immune response (GO:0052572) | 3.96994501 |
| 24 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.96994501 |
| 25 | macrophage activation (GO:0042116) | 3.93711764 |
| 26 | folic acid transport (GO:0015884) | 3.93020782 |
| 27 | glycosphingolipid catabolic process (GO:0046479) | 3.83677704 |
| 28 | regulation of interferon-alpha production (GO:0032647) | 3.83164563 |
| 29 | response to host (GO:0075136) | 3.78097089 |
| 30 | response to host defenses (GO:0052200) | 3.78097089 |
| 31 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.78097089 |
| 32 | pinocytosis (GO:0006907) | 3.71793734 |
| 33 | response to acidic pH (GO:0010447) | 3.63669199 |
| 34 | adhesion of symbiont to host (GO:0044406) | 3.59201289 |
| 35 | hyaluronan catabolic process (GO:0030214) | 3.55917230 |
| 36 | phagosome maturation (GO:0090382) | 3.53061270 |
| 37 | folic acid metabolic process (GO:0046655) | 3.44695746 |
| 38 | negative regulation of mast cell activation (GO:0033004) | 3.43136505 |
| 39 | glycolipid catabolic process (GO:0019377) | 3.40712925 |
| 40 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.39095232 |
| 41 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.36630306 |
| 42 | regulation of cholesterol storage (GO:0010885) | 3.34799547 |
| 43 | positive regulation of antigen processing and presentation (GO:0002579) | 3.33668894 |
| 44 | positive regulation of mast cell degranulation (GO:0043306) | 3.31382590 |
| 45 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.31382590 |
| 46 | positive regulation of B cell differentiation (GO:0045579) | 3.29719928 |
| 47 | cellular response to cadmium ion (GO:0071276) | 3.25542210 |
| 48 | positive regulation of leukocyte degranulation (GO:0043302) | 3.25217937 |
| 49 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.22431871 |
| 50 | vitamin transmembrane transport (GO:0035461) | 3.21199444 |
| 51 | positive regulation of interferon-beta production (GO:0032728) | 3.21169655 |
| 52 | cellular response to zinc ion (GO:0071294) | 3.18761743 |
| 53 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 3.14532490 |
| 54 | response to xenobiotic stimulus (GO:0009410) | 3.13409056 |
| 55 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.13345422 |
| 56 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.13345422 |
| 57 | neutrophil activation involved in immune response (GO:0002283) | 3.13137801 |
| 58 | adenosine receptor signaling pathway (GO:0001973) | 3.11957047 |
| 59 | transferrin transport (GO:0033572) | 3.08936328 |
| 60 | response to pH (GO:0009268) | 3.08643188 |
| 61 | negative regulation of macrophage differentiation (GO:0045650) | 3.07973478 |
| 62 | amino sugar catabolic process (GO:0046348) | 3.07567449 |
| 63 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 3.06161878 |
| 64 | cellular extravasation (GO:0045123) | 3.04562736 |
| 65 | negative regulation of interleukin-12 production (GO:0032695) | 3.01782203 |
| 66 | low-density lipoprotein particle clearance (GO:0034383) | 2.99339469 |
| 67 | negative regulation of interleukin-6 production (GO:0032715) | 2.96313813 |
| 68 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.95791604 |
| 69 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.94988889 |
| 70 | ganglioside metabolic process (GO:0001573) | 2.93169752 |
| 71 | positive regulation of mast cell activation (GO:0033005) | 2.92992252 |
| 72 | ceramide catabolic process (GO:0046514) | 2.92749125 |
| 73 | negative regulation of interleukin-1 production (GO:0032692) | 2.91938477 |
| 74 | regulation of macrophage chemotaxis (GO:0010758) | 2.91130052 |
| 75 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.90126464 |
| 76 | B cell mediated immunity (GO:0019724) | 2.90089798 |
| 77 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.89195255 |
| 78 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.89195255 |
| 79 | regulation of SMAD protein import into nucleus (GO:0060390) | 2.88270858 |
| 80 | cellular response to arsenic-containing substance (GO:0071243) | 2.88152685 |
| 81 | macrophage differentiation (GO:0030225) | 2.85307580 |
| 82 | trivalent inorganic cation transport (GO:0072512) | 2.85078779 |
| 83 | ferric iron transport (GO:0015682) | 2.85078779 |
| 84 | interferon-gamma secretion (GO:0072643) | 2.84597437 |
| 85 | glycosphingolipid metabolic process (GO:0006687) | 2.84298413 |
| 86 | myeloid cell activation involved in immune response (GO:0002275) | 2.84160692 |
| 87 | response to peptidoglycan (GO:0032494) | 2.83111706 |
| 88 | regulation of mast cell activation (GO:0033003) | 2.82443749 |
| 89 | protein carboxylation (GO:0018214) | 2.82248332 |
| 90 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.82248332 |
| 91 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.81234891 |
| 92 | intracellular pH reduction (GO:0051452) | 2.80912045 |
| 93 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.80706091 |
| 94 | respiratory burst (GO:0045730) | 2.80415735 |
| 95 | regulation of antigen processing and presentation (GO:0002577) | 2.79879669 |
| 96 | alanine transport (GO:0032328) | 2.79064925 |
| 97 | decidualization (GO:0046697) | 2.78221453 |
| 98 | eosinophil chemotaxis (GO:0048245) | 2.78194460 |
| 99 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.75170857 |
| 100 | pH reduction (GO:0045851) | 2.75158497 |
| 101 | regulation of interferon-beta production (GO:0032648) | 2.74918268 |
| 102 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.72554073 |
| 103 | purine nucleobase biosynthetic process (GO:0009113) | 2.72037642 |
| 104 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.70562734 |
| 105 | glycosylceramide metabolic process (GO:0006677) | 2.70502191 |
| 106 | chondroitin sulfate catabolic process (GO:0030207) | 2.70263861 |
| 107 | negative regulation of interleukin-1 beta production (GO:0032691) | 2.70121414 |
| 108 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.70120090 |
| 109 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.70082415 |
| 110 | regulation of chemokine secretion (GO:0090196) | 2.68616218 |
| 111 | endosome to melanosome transport (GO:0035646) | 2.66288903 |
| 112 | endosome to pigment granule transport (GO:0043485) | 2.66288903 |
| 113 | cyclooxygenase pathway (GO:0019371) | 2.64772818 |
| 114 | regulation of leukocyte degranulation (GO:0043300) | 2.64642153 |
| 115 | autophagic vacuole assembly (GO:0000045) | 2.64481948 |
| 116 | fucose metabolic process (GO:0006004) | 2.62854481 |
| 117 | oligosaccharide catabolic process (GO:0009313) | 2.62565255 |
| 118 | response to magnesium ion (GO:0032026) | 2.61332796 |
| 119 | sphingolipid catabolic process (GO:0030149) | 2.59753772 |
| 120 | pantothenate metabolic process (GO:0015939) | 2.58509153 |
| 121 | regulation of early endosome to late endosome transport (GO:2000641) | 2.56575441 |
| 122 | glucosamine-containing compound catabolic process (GO:1901072) | 2.55751633 |
| 123 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.55186021 |
| 124 | complement activation, classical pathway (GO:0006958) | 2.54235845 |
| 125 | response to thyroid hormone (GO:0097066) | 2.53022180 |
| 126 | complement activation (GO:0006956) | 2.52851106 |
| 127 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.52522359 |
| 128 | negative regulation of platelet activation (GO:0010544) | 2.52294404 |
| 129 | complement activation, alternative pathway (GO:0006957) | 2.51370365 |
| 130 | modified amino acid transport (GO:0072337) | 2.51340062 |
| 131 | regulation of phagocytosis (GO:0050764) | 2.51165291 |
| 132 | cofactor catabolic process (GO:0051187) | 2.50683626 |
| 133 | N-acetylneuraminate metabolic process (GO:0006054) | 2.50514208 |
| 134 | regulation of autophagic vacuole assembly (GO:2000785) | 2.50393597 |
| 135 | negative regulation of protein autophosphorylation (GO:0031953) | 2.49333652 |
| 136 | plasma lipoprotein particle clearance (GO:0034381) | 2.49328412 |
| 137 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.49057349 |
| 138 | response to laminar fluid shear stress (GO:0034616) | 2.48367589 |
| 139 | cellular response to pH (GO:0071467) | 2.48218572 |
| 140 | regulation of mononuclear cell migration (GO:0071675) | 2.48155072 |
| 141 | cellular iron ion homeostasis (GO:0006879) | 2.47555489 |
| 142 | basic amino acid transport (GO:0015802) | 2.46461491 |
| 143 | detection of molecule of bacterial origin (GO:0032490) | 2.45927158 |
| 144 | eosinophil migration (GO:0072677) | 2.45887171 |
| 145 | I-kappaB phosphorylation (GO:0007252) | 2.45706762 |
| 146 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.45661539 |
| 147 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.45017686 |
| 148 | regulation of integrin activation (GO:0033623) | 2.44594199 |
| 149 | activation of protein kinase B activity (GO:0032148) | 2.44005122 |
| 150 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.43162904 |
| 151 | vacuole organization (GO:0007033) | 2.42588986 |
| 152 | substrate-dependent cell migration (GO:0006929) | 2.42234512 |
| 153 | regulation of mast cell degranulation (GO:0043304) | 2.41731966 |
| 154 | sphingosine metabolic process (GO:0006670) | 2.39749395 |
| 155 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.38259334 |
| 156 | positive regulation of calcium-mediated signaling (GO:0050850) | 2.37911660 |
| 157 | serine transport (GO:0032329) | 2.36668955 |
| 158 | monocyte chemotaxis (GO:0002548) | 2.36625587 |
| 159 | response to muscle activity (GO:0014850) | 2.36579553 |
| 160 | nitric oxide biosynthetic process (GO:0006809) | 2.36359000 |
| 161 | membrane lipid catabolic process (GO:0046466) | 2.36178572 |
| 162 | positive regulation of phagocytosis (GO:0050766) | 2.36020161 |
| 163 | lysosome organization (GO:0007040) | 2.35530617 |
| 164 | lytic vacuole organization (GO:0080171) | 2.35530617 |
| 165 | regulation of chemokine-mediated signaling pathway (GO:0070099) | 2.35355456 |
| 166 | phagocytosis, recognition (GO:0006910) | 2.33099421 |
| 167 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.32779377 |
| 168 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.32063638 |
| 169 | iron ion transport (GO:0006826) | 2.30601116 |
| 170 | autophagic vacuole fusion (GO:0000046) | 2.28919545 |
| 171 | glial cell migration (GO:0008347) | 2.28797841 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.97845627 |
| 2 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.09578966 |
| 3 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 3.08314108 |
| 4 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.93094590 |
| 5 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.77386341 |
| 6 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.59916464 |
| 7 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.53696696 |
| 8 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.46733980 |
| 9 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.43968991 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.41202111 |
| 11 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.39758788 |
| 12 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.23036151 |
| 13 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.22213773 |
| 14 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.20688328 |
| 15 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.05784088 |
| 16 | * FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.04923822 |
| 17 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.97738907 |
| 18 | MYC_22102868_ChIP-Seq_BL_Human | 1.95067333 |
| 19 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.93741773 |
| 20 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.91512283 |
| 21 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.90491933 |
| 22 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.88844159 |
| 23 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.84667637 |
| 24 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.84588324 |
| 25 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.83861122 |
| 26 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.83406571 |
| 27 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.82429963 |
| 28 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.80254999 |
| 29 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.78424090 |
| 30 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.73840605 |
| 31 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.68802748 |
| 32 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.65269368 |
| 33 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.65049850 |
| 34 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.64459406 |
| 35 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.63951287 |
| 36 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.63607991 |
| 37 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.61963407 |
| 38 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.54562644 |
| 39 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.52599486 |
| 40 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.51650494 |
| 41 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.51299839 |
| 42 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.49128684 |
| 43 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.48672673 |
| 44 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.48278573 |
| 45 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48084052 |
| 46 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.47890150 |
| 47 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.45529216 |
| 48 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.45400433 |
| 49 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.45115546 |
| 50 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.43008727 |
| 51 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.42051480 |
| 52 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.41279761 |
| 53 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.40379446 |
| 54 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.40042940 |
| 55 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.39916753 |
| 56 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.39708322 |
| 57 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.38664936 |
| 58 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.36992814 |
| 59 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.36009495 |
| 60 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.34628427 |
| 61 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.34600927 |
| 62 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.32654437 |
| 63 | MAF_26560356_Chip-Seq_TH1_Human | 1.32631684 |
| 64 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.32300091 |
| 65 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.32280610 |
| 66 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.30348741 |
| 67 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30196639 |
| 68 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.29581883 |
| 69 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.28899636 |
| 70 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.28254431 |
| 71 | ERA_21632823_ChIP-Seq_H3396_Human | 1.27731257 |
| 72 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.27072467 |
| 73 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.25641598 |
| 74 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.24056165 |
| 75 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.23545829 |
| 76 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.22767965 |
| 77 | P68_20966046_ChIP-Seq_HELA_Human | 1.22417360 |
| 78 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.22297730 |
| 79 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.22036010 |
| 80 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.21996899 |
| 81 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.21316367 |
| 82 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.20906415 |
| 83 | RAC3_21632823_ChIP-Seq_H3396_Human | 1.20830681 |
| 84 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.19957376 |
| 85 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.18322252 |
| 86 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.18291824 |
| 87 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.17343897 |
| 88 | GATA1_22025678_ChIP-Seq_K562_Human | 1.17227611 |
| 89 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.16963895 |
| 90 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.15831369 |
| 91 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.15538498 |
| 92 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.15457575 |
| 93 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.15299915 |
| 94 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.15118654 |
| 95 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.14980446 |
| 96 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.14766802 |
| 97 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.13837347 |
| 98 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.12395401 |
| 99 | ATF3_27146783_Chip-Seq_COLON_Human | 1.10500221 |
| 100 | SA1_27219007_Chip-Seq_Bcells_Human | 1.10319286 |
| 101 | UTX_26944678_Chip-Seq_JUKART_Human | 1.10108906 |
| 102 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.09885044 |
| 103 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.09111285 |
| 104 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.08320741 |
| 105 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.08178269 |
| 106 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.07470717 |
| 107 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.05146646 |
| 108 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.05065844 |
| 109 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.04969317 |
| 110 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.04600486 |
| 111 | MYB_26560356_Chip-Seq_TH1_Human | 1.04286393 |
| 112 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.03900472 |
| 113 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.03608575 |
| 114 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.03480279 |
| 115 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.03376258 |
| 116 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.03243835 |
| 117 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.02693116 |
| 118 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.02444252 |
| 119 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.02348340 |
| 120 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.01817204 |
| 121 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.01521195 |
| 122 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.01447391 |
| 123 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.01105372 |
| 124 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.00637508 |
| 125 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.00358771 |
| 126 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.00133431 |
| 127 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.00026198 |
| 128 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.99660491 |
| 129 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.99294422 |
| 130 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.99138895 |
| 131 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.99067291 |
| 132 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.98726754 |
| 133 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.98451389 |
| 134 | MITF_21258399_ChIP-Seq_MELANOMA_Human | 0.98329573 |
| 135 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.97617405 |
| 136 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.97229857 |
| 137 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.97223196 |
| 138 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.97148818 |
| 139 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.96811770 |
| 140 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.95485486 |
| 141 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.94979880 |
| 142 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.94974397 |
| 143 | MYB_26560356_Chip-Seq_TH2_Human | 0.94803082 |
| 144 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.94521705 |
| 145 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.94294815 |
| 146 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.93869356 |
| 147 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.93864937 |
| 148 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.93846936 |
| 149 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.93437850 |
| 150 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.93166738 |
| 151 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.93103374 |
| 152 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.92940557 |
| 153 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.92758567 |
| 154 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.92756181 |
| 155 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.92459224 |
| 156 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.91263172 |
| 157 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.89635227 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005058_abnormal_lysosome_morphology | 5.89085321 |
| 2 | MP0003191_abnormal_cellular_cholesterol | 3.97196502 |
| 3 | * MP0009840_abnormal_foam_cell | 3.87804310 |
| 4 | MP0003806_abnormal_nucleotide_metabolis | 3.32496237 |
| 5 | MP0003172_abnormal_lysosome_physiology | 3.29547485 |
| 6 | MP0003303_peritoneal_inflammation | 3.13794190 |
| 7 | MP0006082_CNS_inflammation | 3.05238122 |
| 8 | MP0002837_dystrophic_cardiac_calcinosis | 2.94494522 |
| 9 | MP0005167_abnormal_blood-brain_barrier | 2.54637681 |
| 10 | MP0001835_abnormal_antigen_presentation | 2.50554039 |
| 11 | MP0003436_decreased_susceptibility_to | 2.33846504 |
| 12 | * MP0002419_abnormal_innate_immunity | 2.22178816 |
| 13 | MP0008438_abnormal_cutaneous_collagen | 2.21119232 |
| 14 | MP0003705_abnormal_hypodermis_morpholog | 2.20349488 |
| 15 | MP0005464_abnormal_platelet_physiology | 2.05882805 |
| 16 | MP0003195_calcinosis | 1.99164084 |
| 17 | MP0002254_reproductive_system_inflammat | 1.87864696 |
| 18 | MP0003693_abnormal_embryo_hatching | 1.85632983 |
| 19 | MP0003690_abnormal_glial_cell | 1.84801194 |
| 20 | MP0000749_muscle_degeneration | 1.82786104 |
| 21 | MP0001533_abnormal_skeleton_physiology | 1.75983488 |
| 22 | MP0010386_abnormal_urinary_bladder | 1.70961428 |
| 23 | MP0003566_abnormal_cell_adhesion | 1.68297017 |
| 24 | MP0005000_abnormal_immune_tolerance | 1.67734389 |
| 25 | * MP0002452_abnormal_antigen_presenting | 1.67501243 |
| 26 | MP0000604_amyloidosis | 1.65158924 |
| 27 | MP0004510_myositis | 1.64347465 |
| 28 | MP0000015_abnormal_ear_pigmentation | 1.63291887 |
| 29 | MP0003075_altered_response_to | 1.61912959 |
| 30 | MP0010307_abnormal_tumor_latency | 1.60635839 |
| 31 | MP0003329_amyloid_beta_deposits | 1.59996814 |
| 32 | MP0000465_gastrointestinal_hemorrhage | 1.58449110 |
| 33 | MP0009333_abnormal_splenocyte_physiolog | 1.56027376 |
| 34 | MP0005360_urolithiasis | 1.54332916 |
| 35 | MP0005025_abnormal_response_to | 1.52725867 |
| 36 | MP0006054_spinal_hemorrhage | 1.52427828 |
| 37 | MP0005670_abnormal_white_adipose | 1.47974921 |
| 38 | MP0009764_decreased_sensitivity_to | 1.47055622 |
| 39 | MP0002723_abnormal_immune_serum | 1.46139334 |
| 40 | MP0004185_abnormal_adipocyte_glucose | 1.45153915 |
| 41 | MP0009278_abnormal_bone_marrow | 1.44842427 |
| 42 | MP0000343_altered_response_to | 1.44520733 |
| 43 | MP0003724_increased_susceptibility_to | 1.43393972 |
| 44 | MP0008875_abnormal_xenobiotic_pharmacok | 1.43223506 |
| 45 | MP0001800_abnormal_humoral_immune | 1.42676667 |
| 46 | MP0008469_abnormal_protein_level | 1.41250676 |
| 47 | MP0005671_abnormal_response_to | 1.40551267 |
| 48 | MP0003300_gastrointestinal_ulcer | 1.39812389 |
| 49 | MP0005595_abnormal_vascular_smooth | 1.37886578 |
| 50 | MP0003646_muscle_fatigue | 1.36274672 |
| 51 | MP0001790_abnormal_immune_system | 1.35668371 |
| 52 | MP0005387_immune_system_phenotype | 1.35668371 |
| 53 | MP0010329_abnormal_lipoprotein_level | 1.31624629 |
| 54 | * MP0001819_abnormal_immune_cell | 1.31118027 |
| 55 | MP0005397_hematopoietic_system_phenotyp | 1.30703780 |
| 56 | MP0001545_abnormal_hematopoietic_system | 1.30703780 |
| 57 | MP0005165_increased_susceptibility_to | 1.30267942 |
| 58 | * MP0002420_abnormal_adaptive_immunity | 1.28475828 |
| 59 | * MP0000609_abnormal_liver_physiology | 1.28467998 |
| 60 | MP0001849_ear_inflammation | 1.27965894 |
| 61 | MP0002148_abnormal_hypersensitivity_rea | 1.27838404 |
| 62 | MP0003718_maternal_effect | 1.26832721 |
| 63 | * MP0000689_abnormal_spleen_morphology | 1.25324037 |
| 64 | MP0004947_skin_inflammation | 1.24940502 |
| 65 | MP0002295_abnormal_pulmonary_circulatio | 1.23228768 |
| 66 | MP0001845_abnormal_inflammatory_respons | 1.22979154 |
| 67 | MP0005310_abnormal_salivary_gland | 1.22855431 |
| 68 | MP0002396_abnormal_hematopoietic_system | 1.21989733 |
| 69 | MP0008260_abnormal_autophagy | 1.21962500 |
| 70 | MP0004130_abnormal_muscle_cell | 1.20904591 |
| 71 | MP0002405_respiratory_system_inflammati | 1.19544667 |
| 72 | MP0003879_abnormal_hair_cell | 1.18840645 |
| 73 | MP0008004_abnormal_stomach_pH | 1.14904986 |
| 74 | MP0003448_altered_tumor_morphology | 1.14370632 |
| 75 | MP0000747_muscle_weakness | 1.14162246 |
| 76 | MP0001542_abnormal_bone_strength | 1.13961717 |
| 77 | MP0005023_abnormal_wound_healing | 1.13931424 |
| 78 | MP0001756_abnormal_urination | 1.13804798 |
| 79 | MP0001851_eye_inflammation | 1.12633449 |
| 80 | MP0000569_abnormal_digit_pigmentation | 1.12563804 |
| 81 | MP0000685_abnormal_immune_system | 1.10777393 |
| 82 | MP0000751_myopathy | 1.09975839 |
| 83 | MP0005451_abnormal_body_composition | 1.07326725 |
| 84 | * MP0000716_abnormal_immune_system | 1.05761219 |
| 85 | MP0003183_abnormal_peptide_metabolism | 1.04805165 |
| 86 | MP0010352_gastrointestinal_tract_polyps | 1.04569436 |
| 87 | * MP0002722_abnormal_immune_system | 1.04415974 |
| 88 | MP0000598_abnormal_liver_morphology | 1.03780941 |
| 89 | MP0003828_pulmonary_edema | 1.00728814 |
| 90 | MP0005257_abnormal_intraocular_pressure | 1.00032347 |
| 91 | MP0005166_decreased_susceptibility_to | 0.99791289 |
| 92 | MP0003634_abnormal_glial_cell | 0.99790654 |
| 93 | MP0010368_abnormal_lymphatic_system | 0.99473695 |
| 94 | MP0003111_abnormal_nucleus_morphology | 0.98978895 |
| 95 | MP0003011_delayed_dark_adaptation | 0.98451181 |
| 96 | MP0003950_abnormal_plasma_membrane | 0.97457913 |
| 97 | MP0005174_abnormal_tail_pigmentation | 0.97360608 |
| 98 | MP0005330_cardiomyopathy | 0.95880067 |
| 99 | MP0005076_abnormal_cell_differentiation | 0.95559996 |
| 100 | * MP0002429_abnormal_blood_cell | 0.95445705 |
| 101 | MP0004019_abnormal_vitamin_homeostasis | 0.95404115 |
| 102 | MP0001915_intracranial_hemorrhage | 0.95297242 |
| 103 | MP0005365_abnormal_bile_salt | 0.95264244 |
| 104 | MP0002998_abnormal_bone_remodeling | 0.95205104 |
| 105 | MP0004782_abnormal_surfactant_physiolog | 0.94908629 |
| 106 | MP0004084_abnormal_cardiac_muscle | 0.94688208 |
| 107 | MP0003656_abnormal_erythrocyte_physiolo | 0.94305529 |
| 108 | MP0002398_abnormal_bone_marrow | 0.93863354 |
| 109 | MP0000538_abnormal_urinary_bladder | 0.93626611 |
| 110 | MP0002269_muscular_atrophy | 0.93463907 |
| 111 | MP0000920_abnormal_myelination | 0.92614088 |
| 112 | MP0000750_abnormal_muscle_regeneration | 0.92317651 |
| 113 | MP0009785_altered_susceptibility_to | 0.92312263 |
| 114 | MP0008007_abnormal_cellular_replicative | 0.91251712 |
| 115 | MP0003279_aneurysm | 0.90722843 |
| 116 | MP0005390_skeleton_phenotype | 0.89143465 |
| 117 | MP0003137_abnormal_impulse_conducting | 0.88841354 |
| 118 | MP0003633_abnormal_nervous_system | 0.88019385 |
| 119 | MP0000858_altered_metastatic_potential | 0.87581835 |
| 120 | MP0009643_abnormal_urine_homeostasis | 0.87505851 |
| 121 | MP0001853_heart_inflammation | 0.86922113 |
| 122 | MP0002136_abnormal_kidney_physiology | 0.86483027 |
| 123 | MP0000371_diluted_coat_color | 0.84650333 |
| 124 | MP0005666_abnormal_adipose_tissue | 0.84543900 |
| 125 | MP0001958_emphysema | 0.84365910 |
| 126 | MP0004036_abnormal_muscle_relaxation | 0.83856375 |
| 127 | MP0002090_abnormal_vision | 0.83633277 |
| 128 | MP0004883_abnormal_blood_vessel | 0.83179061 |
| 129 | MP0005319_abnormal_enzyme/_coenzyme | 0.83166113 |
| 130 | MP0003186_abnormal_redox_activity | 0.82034057 |
| 131 | MP0000490_abnormal_crypts_of | 0.80411172 |
| 132 | MP0004233_abnormal_muscle_weight | 0.80309898 |
| 133 | MP0009763_increased_sensitivity_to | 0.80195087 |
| 134 | MP0001986_abnormal_taste_sensitivity | 0.77818512 |
| 135 | MP0000767_abnormal_smooth_muscle | 0.77765593 |
| 136 | * MP0000249_abnormal_blood_vessel | 0.76811013 |
| 137 | MP0004272_abnormal_basement_membrane | 0.76727608 |
| 138 | MP0004808_abnormal_hematopoietic_stem | 0.76654303 |
| 139 | * MP0002118_abnormal_lipid_homeostasis | 0.76623884 |
| 140 | MP0008873_increased_physiological_sensi | 0.76207376 |
| 141 | MP0005410_abnormal_fertilization | 0.75300562 |
| 142 | MP0005395_other_phenotype | 0.74918701 |
| 143 | MP0005164_abnormal_response_to | 0.74623487 |
| 144 | MP0002139_abnormal_hepatobiliary_system | 0.74450499 |
| 145 | MP0003795_abnormal_bone_structure | 0.72235530 |
| 146 | MP0002896_abnormal_bone_mineralization | 0.72083667 |
| 147 | MP0002933_joint_inflammation | 0.70830350 |
| 148 | MP0002653_abnormal_ependyma_morphology | 0.70628761 |
| 149 | MP0002138_abnormal_hepatobiliary_system | 0.66761157 |
| 150 | MP0002229_neurodegeneration | 0.65913869 |
| 151 | MP0002972_abnormal_cardiac_muscle | 0.64629422 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Systemic lupus erythematosus (HP:0002725) | 7.51073497 |
| 2 | Abnormality of liposaccharide metabolism (HP:0010968) | 6.40688683 |
| 3 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 6.40688683 |
| 4 | Abnormality of glycolipid metabolism (HP:0010969) | 6.40688683 |
| 5 | Glomerulonephritis (HP:0000099) | 5.77031296 |
| 6 | Increased cerebral lipofuscin (HP:0011813) | 5.75561219 |
| 7 | Dysostosis multiplex (HP:0000943) | 5.35855012 |
| 8 | Vacuolated lymphocytes (HP:0001922) | 5.12268646 |
| 9 | Complement deficiency (HP:0004431) | 5.03243197 |
| 10 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.71474406 |
| 11 | Abnormality of complement system (HP:0005339) | 4.17186479 |
| 12 | Recurrent abscess formation (HP:0002722) | 4.10675999 |
| 13 | Mucopolysacchariduria (HP:0008155) | 3.95494663 |
| 14 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.95494663 |
| 15 | Recurrent bacterial skin infections (HP:0005406) | 3.81342215 |
| 16 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.73783870 |
| 17 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.73783870 |
| 18 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.73783870 |
| 19 | Cerebral aneurysm (HP:0004944) | 3.72552917 |
| 20 | Disinhibition (HP:0000734) | 3.68216680 |
| 21 | Nuclear cataract (HP:0100018) | 3.65590905 |
| 22 | Axonal loss (HP:0003447) | 3.58925174 |
| 23 | Mutism (HP:0002300) | 3.57745390 |
| 24 | Abnormality of macrophages (HP:0004311) | 3.41944223 |
| 25 | Eczematoid dermatitis (HP:0000976) | 3.41178073 |
| 26 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.27599660 |
| 27 | Nephritis (HP:0000123) | 3.14609285 |
| 28 | Agnosia (HP:0010524) | 3.02802088 |
| 29 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.01346297 |
| 30 | Upper motor neuron abnormality (HP:0002127) | 2.99834714 |
| 31 | Loss of speech (HP:0002371) | 2.98768824 |
| 32 | Global brain atrophy (HP:0002283) | 2.97549410 |
| 33 | Pustule (HP:0200039) | 2.91543107 |
| 34 | Retinal atrophy (HP:0001105) | 2.86215639 |
| 35 | Personality changes (HP:0000751) | 2.82015643 |
| 36 | Purpura (HP:0000979) | 2.71807416 |
| 37 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.69447914 |
| 38 | Osteolytic defects of the hand bones (HP:0009699) | 2.69447914 |
| 39 | Progressive neurologic deterioration (HP:0002344) | 2.69315984 |
| 40 | Myocardial infarction (HP:0001658) | 2.67163629 |
| 41 | Hematochezia (HP:0002573) | 2.61741887 |
| 42 | Hepatosplenomegaly (HP:0001433) | 2.61269351 |
| 43 | Inappropriate behavior (HP:0000719) | 2.56263943 |
| 44 | Arterial tortuosity (HP:0005116) | 2.53886896 |
| 45 | Thoracic kyphosis (HP:0002942) | 2.51709959 |
| 46 | Diminished motivation (HP:0000745) | 2.49400523 |
| 47 | Vertebral compression fractures (HP:0002953) | 2.46295306 |
| 48 | Apathy (HP:0000741) | 2.46096657 |
| 49 | Asymmetric septal hypertrophy (HP:0001670) | 2.44769441 |
| 50 | J-shaped sella turcica (HP:0002680) | 2.43936065 |
| 51 | Premature rupture of membranes (HP:0001788) | 2.37835974 |
| 52 | Neuronal loss in central nervous system (HP:0002529) | 2.36740221 |
| 53 | Cervical subluxation (HP:0003308) | 2.36403646 |
| 54 | Vascular tortuosity (HP:0004948) | 2.28127892 |
| 55 | Xanthomatosis (HP:0000991) | 2.25408661 |
| 56 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.24326271 |
| 57 | Clumsiness (HP:0002312) | 2.20611693 |
| 58 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.19976251 |
| 59 | Agitation (HP:0000713) | 2.16642451 |
| 60 | Joint stiffness (HP:0001387) | 2.16488339 |
| 61 | Conjunctival telangiectasia (HP:0000524) | 2.15190282 |
| 62 | Peripheral demyelination (HP:0011096) | 2.14946589 |
| 63 | Protuberant abdomen (HP:0001538) | 2.13209440 |
| 64 | Interstitial pulmonary disease (HP:0006530) | 2.13055684 |
| 65 | Polycythemia (HP:0001901) | 2.09470923 |
| 66 | Bone cyst (HP:0012062) | 2.07868423 |
| 67 | Recurrent skin infections (HP:0001581) | 2.07558545 |
| 68 | Pathologic fracture (HP:0002756) | 2.03709961 |
| 69 | Spondylolisthesis (HP:0003302) | 2.01834543 |
| 70 | Mesangial abnormality (HP:0001966) | 1.96240117 |
| 71 | Hyperlipoproteinemia (HP:0010980) | 1.95176327 |
| 72 | Esophageal neoplasm (HP:0100751) | 1.94445881 |
| 73 | Neoplasm of head and neck (HP:0012288) | 1.94445881 |
| 74 | Albinism (HP:0001022) | 1.94056596 |
| 75 | Opisthotonus (HP:0002179) | 1.93260057 |
| 76 | Mitral stenosis (HP:0001718) | 1.92803645 |
| 77 | Abnormal neuron morphology (HP:0012757) | 1.92576080 |
| 78 | Abnormality of the motor neurons (HP:0002450) | 1.92576080 |
| 79 | Progressive visual loss (HP:0000529) | 1.92263739 |
| 80 | Zonular cataract (HP:0010920) | 1.91886796 |
| 81 | Abnormality of the lumbar spine (HP:0100712) | 1.91882035 |
| 82 | Hand muscle atrophy (HP:0009130) | 1.91617844 |
| 83 | Spontaneous hematomas (HP:0007420) | 1.89147685 |
| 84 | Metaphyseal irregularity (HP:0003025) | 1.88623324 |
| 85 | Impaired platelet aggregation (HP:0003540) | 1.88014417 |
| 86 | Abnormal platelet function (HP:0011869) | 1.88014417 |
| 87 | Type II lissencephaly (HP:0007260) | 1.86863204 |
| 88 | Abnormality of the thoracic spine (HP:0100711) | 1.86661220 |
| 89 | Aortic aneurysm (HP:0004942) | 1.86155731 |
| 90 | Increased serum ferritin (HP:0003281) | 1.83999273 |
| 91 | Spinal rigidity (HP:0003306) | 1.83365316 |
| 92 | Ovoid vertebral bodies (HP:0003300) | 1.81260506 |
| 93 | Autoimmune thrombocytopenia (HP:0001973) | 1.81256389 |
| 94 | Cardiomegaly (HP:0001640) | 1.80515441 |
| 95 | Abnormality of lateral ventricle (HP:0030047) | 1.80403200 |
| 96 | Obstructive lung disease (HP:0006536) | 1.79687117 |
| 97 | Chronic obstructive pulmonary disease (HP:0006510) | 1.79687117 |
| 98 | Beaking of vertebral bodies (HP:0004568) | 1.78428091 |
| 99 | Basal ganglia calcification (HP:0002135) | 1.77410399 |
| 100 | Poor head control (HP:0002421) | 1.76726602 |
| 101 | Disproportionate tall stature (HP:0001519) | 1.76222751 |
| 102 | Striae distensae (HP:0001065) | 1.74992462 |
| 103 | Spinal muscular atrophy (HP:0007269) | 1.73863031 |
| 104 | Neurodegeneration (HP:0002180) | 1.73577626 |
| 105 | Joint hemorrhage (HP:0005261) | 1.73514860 |
| 106 | Aortic dissection (HP:0002647) | 1.73207536 |
| 107 | Ulnar deviation of the wrist (HP:0003049) | 1.72965776 |
| 108 | Increased CSF protein (HP:0002922) | 1.72559565 |
| 109 | Recurrent fungal infections (HP:0002841) | 1.71934573 |
| 110 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.71934356 |
| 111 | Gingivitis (HP:0000230) | 1.71350521 |
| 112 | Deep venous thrombosis (HP:0002625) | 1.68544491 |
| 113 | Colitis (HP:0002583) | 1.68291413 |
| 114 | Petechiae (HP:0000967) | 1.67661294 |
| 115 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.67513908 |
| 116 | Diaphragmatic weakness (HP:0009113) | 1.66720688 |
| 117 | Prolonged neonatal jaundice (HP:0006579) | 1.65890922 |
| 118 | Dementia (HP:0000726) | 1.64558980 |
| 119 | Abnormality of proline metabolism (HP:0010907) | 1.64432441 |
| 120 | Hydroxyprolinuria (HP:0003080) | 1.64432441 |
| 121 | Neurofibrillary tangles (HP:0002185) | 1.63767009 |
| 122 | Hypoalphalipoproteinemia (HP:0003233) | 1.63669262 |
| 123 | Hypoplasia of the odontoid process (HP:0003311) | 1.62937415 |
| 124 | Myoclonus (HP:0001336) | 1.62918331 |
| 125 | Achilles tendon contracture (HP:0001771) | 1.62815053 |
| 126 | Cerebral inclusion bodies (HP:0100314) | 1.61084283 |
| 127 | Polygenic inheritance (HP:0010982) | 1.60256069 |
| 128 | Amyloidosis (HP:0011034) | 1.59687107 |
| 129 | Myositis (HP:0100614) | 1.59250714 |
| 130 | Microretrognathia (HP:0000308) | 1.57192833 |
| 131 | Generalized amyotrophy (HP:0003700) | 1.57142248 |
| 132 | Long toe (HP:0010511) | 1.57121440 |
| 133 | Abnormality of iron homeostasis (HP:0011031) | 1.56214183 |
| 134 | Frequent falls (HP:0002359) | 1.55792000 |
| 135 | Supranuclear gaze palsy (HP:0000605) | 1.53340247 |
| 136 | Deformed sella turcica (HP:0002681) | 1.50607836 |
| 137 | Breast hypoplasia (HP:0003187) | 1.49923978 |
| 138 | Muscular dystrophy (HP:0003560) | 1.44838238 |
| 139 | Bulbar palsy (HP:0001283) | 1.43700956 |
| 140 | Distal lower limb muscle weakness (HP:0009053) | 1.43417850 |
| 141 | Abnormality of the vertebral endplates (HP:0005106) | 1.42851840 |
| 142 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.42487170 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TGFBR2 | 5.04284973 |
| 2 | PINK1 | 3.88427694 |
| 3 | EPHA2 | 3.19352743 |
| 4 | ERN1 | 3.12006300 |
| 5 | BLK | 3.07271996 |
| 6 | TRIB3 | 3.03683360 |
| 7 | BUB1 | 2.98325761 |
| 8 | TYK2 | 2.71586213 |
| 9 | BMPR1B | 2.66729216 |
| 10 | ADRBK2 | 2.55449676 |
| 11 | CAMK1D | 2.46266026 |
| 12 | CSF1R | 2.37565389 |
| 13 | DAPK2 | 2.22877118 |
| 14 | MAP4K1 | 2.21011768 |
| 15 | PAK4 | 2.19839330 |
| 16 | CAMKK2 | 2.11376594 |
| 17 | TGFBR1 | 2.10325687 |
| 18 | TSSK6 | 2.10014631 |
| 19 | PKN2 | 1.96379630 |
| 20 | RIPK4 | 1.90588529 |
| 21 | STK10 | 1.80792335 |
| 22 | MYLK | 1.76669180 |
| 23 | IRAK3 | 1.74600191 |
| 24 | LIMK1 | 1.68472937 |
| 25 | SCYL2 | 1.67145716 |
| 26 | MAP2K3 | 1.64958880 |
| 27 | TBK1 | 1.64725832 |
| 28 | OBSCN | 1.59056953 |
| 29 | NEK2 | 1.57592161 |
| 30 | MAPK15 | 1.56791311 |
| 31 | KIT | 1.56358193 |
| 32 | EPHB2 | 1.53119676 |
| 33 | MAP2K6 | 1.48098583 |
| 34 | WEE1 | 1.47890944 |
| 35 | ARAF | 1.42510709 |
| 36 | TESK1 | 1.41322564 |
| 37 | EEF2K | 1.36958198 |
| 38 | ZAP70 | 1.33801891 |
| 39 | CAMK1G | 1.32629603 |
| 40 | PHKG2 | 1.29203194 |
| 41 | PHKG1 | 1.29203194 |
| 42 | RPS6KA4 | 1.25326131 |
| 43 | CAMKK1 | 1.21614692 |
| 44 | TIE1 | 1.18127758 |
| 45 | FRK | 1.17283499 |
| 46 | MAP3K1 | 1.16690282 |
| 47 | GRK7 | 1.15722266 |
| 48 | MOS | 1.13372514 |
| 49 | JAK1 | 1.12998944 |
| 50 | MAP3K3 | 1.12732686 |
| 51 | PRKG2 | 1.11506647 |
| 52 | PRKD2 | 1.11431774 |
| 53 | PIM2 | 1.07056878 |
| 54 | ADRBK1 | 1.06388762 |
| 55 | MAP3K9 | 1.04617392 |
| 56 | PTK2B | 1.04516878 |
| 57 | CSNK1G3 | 1.03255478 |
| 58 | TAOK3 | 1.03082020 |
| 59 | STK38 | 1.00703842 |
| 60 | FES | 0.99702874 |
| 61 | JAK2 | 0.99638802 |
| 62 | PAK6 | 0.98778144 |
| 63 | NEK9 | 0.94821814 |
| 64 | HCK | 0.94775071 |
| 65 | MAP3K8 | 0.93996217 |
| 66 | MAP3K11 | 0.90229650 |
| 67 | CSNK1A1L | 0.88507106 |
| 68 | EIF2AK1 | 0.86360156 |
| 69 | IKBKB | 0.83858777 |
| 70 | KSR2 | 0.83114513 |
| 71 | MAP2K2 | 0.83010843 |
| 72 | LRRK2 | 0.82919023 |
| 73 | CSNK1G2 | 0.80947850 |
| 74 | ABL2 | 0.80177340 |
| 75 | TLK1 | 0.77585304 |
| 76 | PTK6 | 0.77573648 |
| 77 | EPHB1 | 0.77311495 |
| 78 | FGFR4 | 0.76302466 |
| 79 | TRIM28 | 0.75992682 |
| 80 | CDC42BPA | 0.75761988 |
| 81 | CSK | 0.74990655 |
| 82 | RIPK1 | 0.74690068 |
| 83 | TTK | 0.73787296 |
| 84 | BRSK2 | 0.72908917 |
| 85 | DDR2 | 0.72709424 |
| 86 | PAK2 | 0.72164881 |
| 87 | PDK2 | 0.71155406 |
| 88 | IRAK4 | 0.70744402 |
| 89 | ACVR1B | 0.70484636 |
| 90 | TTN | 0.70394580 |
| 91 | ROCK1 | 0.67438910 |
| 92 | KDR | 0.67107755 |
| 93 | MATK | 0.62934511 |
| 94 | INSRR | 0.62797252 |
| 95 | LMTK2 | 0.62476655 |
| 96 | DAPK3 | 0.62359020 |
| 97 | CAMK1 | 0.59347170 |
| 98 | MAP2K7 | 0.58431825 |
| 99 | CAMK4 | 0.58147433 |
| 100 | STK3 | 0.58004058 |
| 101 | PDPK1 | 0.57630590 |
| 102 | SYK | 0.57489145 |
| 103 | PIM1 | 0.56825387 |
| 104 | CDK6 | 0.56509614 |
| 105 | LYN | 0.55788073 |
| 106 | CLK1 | 0.55482521 |
| 107 | TESK2 | 0.55403266 |
| 108 | ZAK | 0.55358908 |
| 109 | CDK4 | 0.54765523 |
| 110 | BCKDK | 0.53649724 |
| 111 | MAPKAPK3 | 0.53570193 |
| 112 | NME2 | 0.53339221 |
| 113 | TAOK2 | 0.52880141 |
| 114 | TAOK1 | 0.52794639 |
| 115 | PAK1 | 0.52270480 |
| 116 | CSNK1G1 | 0.51926319 |
| 117 | MAP3K13 | 0.51650761 |
| 118 | GRK1 | 0.51568827 |
| 119 | PDK1 | 0.51386860 |
| 120 | ALK | 0.51028177 |
| 121 | MAPK12 | 0.50732826 |
| 122 | FGR | 0.50382240 |
| 123 | PLK4 | 0.50245227 |
| 124 | MAP3K10 | 0.48680438 |
| 125 | JAK3 | 0.46997740 |
| 126 | MAP3K5 | 0.46982352 |
| 127 | AKT3 | 0.46937874 |
| 128 | GRK6 | 0.46087469 |
| 129 | LCK | 0.44822635 |
| 130 | CAMK2D | 0.44721637 |
| 131 | MAP3K6 | 0.44430923 |
| 132 | BTK | 0.44115166 |
| 133 | MAPK4 | 0.44042278 |
| 134 | PTK2 | 0.43799920 |
| 135 | MAP2K1 | 0.43672266 |
| 136 | PRKCQ | 0.42701232 |
| 137 | MAPKAPK2 | 0.41021698 |
| 138 | BRAF | 0.40492756 |
| 139 | RAF1 | 0.40114034 |
| 140 | MUSK | 0.37505849 |
| 141 | MARK3 | 0.36064351 |
| 142 | BMX | 0.35486484 |
| 143 | PRKD1 | 0.34991453 |
| 144 | EGFR | 0.34308523 |
| 145 | RPS6KA6 | 0.33765007 |
| 146 | RPS6KC1 | 0.33333544 |
| 147 | RPS6KL1 | 0.33333544 |
| 148 | MTOR | 0.32671171 |
| 149 | RPS6KA2 | 0.32434708 |
| 150 | PAK3 | 0.31551216 |
| 151 | PRKAA2 | 0.30601343 |
| 152 | SIK2 | 0.30306010 |
| 153 | SIK1 | 0.29987666 |
| 154 | PRKG1 | 0.29590890 |
| 155 | ABL1 | 0.28516731 |
| 156 | WNK4 | 0.27844487 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 4.97328207 |
| 2 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 4.89664909 |
| 3 | Other glycan degradation_Homo sapiens_hsa00511 | 4.65558630 |
| 4 | * Lysosome_Homo sapiens_hsa04142 | 4.20671334 |
| 5 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 3.00899565 |
| 6 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 2.73784203 |
| 7 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.30702836 |
| 8 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.00704574 |
| 9 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.93049371 |
| 10 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.91637877 |
| 11 | Prion diseases_Homo sapiens_hsa05020 | 1.87131409 |
| 12 | Pertussis_Homo sapiens_hsa05133 | 1.85670697 |
| 13 | Leishmaniasis_Homo sapiens_hsa05140 | 1.78311834 |
| 14 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.68434521 |
| 15 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.64733097 |
| 16 | Tuberculosis_Homo sapiens_hsa05152 | 1.58324988 |
| 17 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.51042553 |
| 18 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.47916094 |
| 19 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.47574377 |
| 20 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.45773268 |
| 21 | Phagosome_Homo sapiens_hsa04145 | 1.43435909 |
| 22 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.41573911 |
| 23 | Asthma_Homo sapiens_hsa05310 | 1.37562492 |
| 24 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.37395544 |
| 25 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.36779401 |
| 26 | Mineral absorption_Homo sapiens_hsa04978 | 1.36141014 |
| 27 | Legionellosis_Homo sapiens_hsa05134 | 1.34563828 |
| 28 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.32361733 |
| 29 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.26968107 |
| 30 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.26842809 |
| 31 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.22478909 |
| 32 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.20949550 |
| 33 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.18648008 |
| 34 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.11052139 |
| 35 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.06637438 |
| 36 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.05018366 |
| 37 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.03899803 |
| 38 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.03370848 |
| 39 | Apoptosis_Homo sapiens_hsa04210 | 0.98003553 |
| 40 | Malaria_Homo sapiens_hsa05144 | 0.97533526 |
| 41 | Endocytosis_Homo sapiens_hsa04144 | 0.96225287 |
| 42 | * Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.94486958 |
| 43 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.93457132 |
| 44 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.92003818 |
| 45 | Shigellosis_Homo sapiens_hsa05131 | 0.90652679 |
| 46 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.89319263 |
| 47 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.89006384 |
| 48 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.86654259 |
| 49 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.86014870 |
| 50 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.85019857 |
| 51 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.83821178 |
| 52 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.82309173 |
| 53 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.80491013 |
| 54 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.79954639 |
| 55 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.78986435 |
| 56 | Allograft rejection_Homo sapiens_hsa05330 | 0.73213718 |
| 57 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.71828878 |
| 58 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.71813867 |
| 59 | Bladder cancer_Homo sapiens_hsa05219 | 0.69805279 |
| 60 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.68702561 |
| 61 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.68676662 |
| 62 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.67219104 |
| 63 | Galactose metabolism_Homo sapiens_hsa00052 | 0.67004322 |
| 64 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.66326060 |
| 65 | Measles_Homo sapiens_hsa05162 | 0.65873247 |
| 66 | Influenza A_Homo sapiens_hsa05164 | 0.65147620 |
| 67 | Sulfur relay system_Homo sapiens_hsa04122 | 0.62667387 |
| 68 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.62631651 |
| 69 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.62514070 |
| 70 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.62122263 |
| 71 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.62006679 |
| 72 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.61059414 |
| 73 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.60956367 |
| 74 | Salmonella infection_Homo sapiens_hsa05132 | 0.60423648 |
| 75 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.60371787 |
| 76 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.59071789 |
| 77 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.58966111 |
| 78 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.57213615 |
| 79 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.55799618 |
| 80 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.55771327 |
| 81 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.55467673 |
| 82 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.55457365 |
| 83 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.54622524 |
| 84 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.53983487 |
| 85 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.53432802 |
| 86 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.52931152 |
| 87 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.52449486 |
| 88 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.51893723 |
| 89 | Phototransduction_Homo sapiens_hsa04744 | 0.51514754 |
| 90 | Hepatitis B_Homo sapiens_hsa05161 | 0.51345133 |
| 91 | Amoebiasis_Homo sapiens_hsa05146 | 0.50988139 |
| 92 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.50738884 |
| 93 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.50349484 |
| 94 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.50179514 |
| 95 | Platelet activation_Homo sapiens_hsa04611 | 0.50007358 |
| 96 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.49454652 |
| 97 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.49446907 |
| 98 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.49115733 |
| 99 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.48221669 |
| 100 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.46975057 |
| 101 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.46385647 |
| 102 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.46217878 |
| 103 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.45695979 |
| 104 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.45089413 |
| 105 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.43953278 |
| 106 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.43620503 |
| 107 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.42970350 |
| 108 | ABC transporters_Homo sapiens_hsa02010 | 0.42550084 |
| 109 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.41622713 |
| 110 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.41440837 |
| 111 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.40639420 |
| 112 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.40591247 |
| 113 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.40535007 |
| 114 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.40250636 |
| 115 | Proteasome_Homo sapiens_hsa03050 | 0.40175501 |
| 116 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.39878225 |
| 117 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.39303084 |
| 118 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.39052936 |
| 119 | Insulin resistance_Homo sapiens_hsa04931 | 0.38608778 |
| 120 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.38569808 |
| 121 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.38309189 |
| 122 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.37971146 |
| 123 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.37506380 |
| 124 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.37049542 |
| 125 | RNA transport_Homo sapiens_hsa03013 | 0.36753509 |
| 126 | Cell cycle_Homo sapiens_hsa04110 | 0.36186304 |
| 127 | Colorectal cancer_Homo sapiens_hsa05210 | 0.35552152 |
| 128 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.35297635 |
| 129 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.34824479 |
| 130 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.34029930 |
| 131 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.33416714 |
| 132 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.32887836 |
| 133 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.31486950 |
| 134 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.31032025 |
| 135 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.28996404 |
| 136 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.28707096 |
| 137 | Viral myocarditis_Homo sapiens_hsa05416 | 0.27797342 |
| 138 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.27517602 |
| 139 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.26884490 |
| 140 | Peroxisome_Homo sapiens_hsa04146 | 0.26391214 |
| 141 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.26260968 |
| 142 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.25686559 |
| 143 | Metabolic pathways_Homo sapiens_hsa01100 | 0.25043532 |
| 144 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.22532877 |
| 145 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.20756311 |
| 146 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.20729521 |
| 147 | Focal adhesion_Homo sapiens_hsa04510 | 0.20335800 |
| 148 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.18645549 |
| 149 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.16119599 |
| 150 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.15721613 |
| 151 | Renin secretion_Homo sapiens_hsa04924 | 0.14413397 |

